BPCR
NEUTRALBioPharma Credit PLC Announces Holding Change
The investment company has disclosed a change in a major shareholder's holding.
BioPharma Credit
0.8860USD
-1.55%
Market Cap
1.01B
Volume
5.06k
1% of avg
P/E Ratio
EPS (TTM)
Beta
N/A
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p0.8860p0.9400p
0.8860p
Upcoming Events
Late 2026
Evolus Additional Tranches Availability Deadline
High Impact Event
BPCR
NEUTRALBioPharma Credit PLC Announces Director Appointment
The prominent investment company has announced the appointment of a new Non-Executive Director to its board.
BPCR
GOODBioPharma Credit PLC Completes OptiNose Acquisition and Invests $50 Million in Paratek Pharmaceuticals
The life sciences debt investment trust has completed the acquisition of OptiNose and made a new $50 million investment in Paratek Pharmaceuticals, strengthening its financial position.
BPCR
NEUTRALBioPharma Credit PLC Announces Director/PDMR Shareholding
The company has announced a change in shareholding by a person closely associated with a director.
BPCR
NEUTRALBioPharma Credit PLC Announces Annual General Meeting
The life sciences investment company announces details of its upcoming Annual General Meeting.
BPCR
NEUTRALBioPharma Credit PLC Provides Updates on Investments
The investment trust provides updates on partial prepayment from BioCryst Pharmaceuticals and additional investment commitment to Evolus, Inc.
BPCR
NEUTRALBioPharma Credit Announces Change in Major Shareholding
The asset manager Adage Capital Management has reduced its stake in the investment trust BioPharma Credit PLC.
BPCR
NEUTRALBioPharma Credit Receives $8.25M Settlement from Biogen
The life sciences debt investor has received a settlement payment from Biogen, resolving a dispute over a loan agreement.
BPCR
NEUTRALBioPharma Credit PLC Announces Director Dealings
The major biopharmaceutical investment company has announced changes to its major shareholdings.